Product Liability Archive » January, 2022

Product Liability - January, 2022

239 articles

• Opioid Pills Set Off 'Triple Wave' Of Addiction, Judge Hears
• Suit Says 'Sticky' Beretta Gunstocks Are Defective
• Juul Loses Bid To Dodge Tribes' Claims In Vape MDL
• Elite Trial Lawyer Switches Sides To A Changing Plaintiffs Bar
• Wegmans Whips Vanilla Cake Mix False Ad Suit, For Now
• Feds Tell Jury Ex-Drug Co-Op CEO To Blame For Opioid Crisis
• Pharmacies Can't Get 6th Circ. Review In Ohio Opioid Trial
• Keys To Keeping Law Firm Talent Amid The Great Resignation
• Attys Ask For $27.5M In Apple Warranty Class Settlement
• Paper Mill Can't Duck Noxious Emissions Suit
• Autoliv Says $100M Punitive Damage Award 'Excessive'
• Barnes & Thornburg Adds Product Liability Pro In Dallas
• NJ Demands $943M Funding Source For DuPont Pollution
• GM Gets Most Claims Clipped In Oil-Guzzling Engine Suit
• Target Wants 'Oil-Free' Cosmetics Labeling Suit Pruned
• Ex-NFLers Urge Approval Of Settlement Over Race-Norming
• Texas Justices To Decide Fate Of VW, Audi Parent Cos. Suits
• Drugmakers Won't Get Discovery From Valisure In Zantac MDL
• Purdue's Appeal On Ch. 11 Releases Fast-Tracked By 2nd Circ.
• Groups Restart Lawsuit Seeking Chemours PFAS Tests
• Clyde & Co. Adds Former FAA Counsel As Partner In DC
• Strategies For Coping With Stress In The Legal Profession
• 3M Hit With $110M Verdict In Fla. Military Earplug Bellwether
• 6 Breyer Product, Personal Injury Opinions Attys Should Know
• Evenflo Escapes Deceptive Marketing Booster Seat MDL
• Walmart Seeks Toss Of Suit Over Crash That Killed Girl Scouts
• CPSC Approves New Crib Mattress Safety Rule
• The Term: Breyer's Legacy And The Nomination To Come
• Breyer Retiring As Supreme Court Lurches Right
• Apple, Gibson Dunn Beat COVID App Maker's Sanction Bid
• Calif. High Court Takes Up Fight Over County's Drilling Bans
• 'Street Level' Oxy Pusher Admits Tricking Ex-CEO's Company
• All Pa. Counties Join $26B Opioid Deal Over DAs' Objections
• Vision Biz To Pay $3.5M For Violating Contact Lens Rule
• What You Need To Know About Judge Jackson
• Biden At His Side, Justice Breyer Announces Retirement
• Intel Must Face Trimmed Microprocessor Security Flaw Suit
• 7th Circ. Dismisses Indiana Univ. Students' Vax Mandate Suit
• Democrats Plan Swift Confirmation Of Breyer Successor
• And Now A Word From The Panel: 2021 MDLs In Review
• EPA Declines To Switch Up Ethylene Oxide Risk Calculation
• Meet The Possible Nominees For Justice Breyer's Seat
• How AI Can Transform Crisis Management In Litigation
• Law Firms Seek $18.3M For $238M Deal To End 737 Max Suit
• 'Just Do Your Job': Justice Breyer's Legacy Of Pragmatism
• 5 Breyer Opinions You Need To Know
• Justice Breyer To Retire From High Court
• 'Frankly Stunning': Distributors Pan DEA Vet At Opioid Trial
• Alsup Lambasts PG&E's 'Crime Spree' As Probation Ends
• Mallinckrodt, Fresenius Reach $14M Deal On Supply Claims
• Rhode Island Inks $91M Opioid Deal With Distributors
• The Insys Case Made History. Why An Exec's Appeal May Not
• Supervisor Relationships Are Key To Beating Atty Burnout
• Ex-NFLers, Wives Back Race-Norming Deal, But With Caveats
• How New Laws Could Tighten FDA Regulation Of Cosmetics
• COVID App Developer Wants Apple, Gibson Dunn Sanctioned
• 4th Circ. Judges Press Energy Cos. On Climate Suit's Future
• Sheet Buyer Class Certified In Macy's Thread-Count Suit
• Distributor Urges 6th Circ. To Revive Opioid Coverage Suits
• Beyond Big: Smaller, Hyperfocused Firms Still Stand Out
• Drug Distributors' Order Reporting Had Flaws, Expert Testifies
• VW AG Beats Defective Braking Suit, But Audi Stalls In Court
• Ex-Compliance Boss Walks Fine Line At Oxy Conspiracy Trial
• Greenberg Traurig Adds Health Care Litigation Atty In NJ
• COVID Fuels Top Firms' Priorities In 2022
• The Leaderboard: Tracking A Firm's Litigation Footprint
• Feds, Mining Cos. Ink $90M Deal In Gold King Mine Spill Suit
• Meta, Snap's 'Addictive' Platforms Blamed For Child's Suicide
• Punitive Damages Give Cancer Survivor $10M Win Over RJR
• Roundup Buyers Seek Up To $45M Economic Loss Settlement
• District Court Won't Hear J&J Talc Unit's Ch. 11 Stay Fight
• $26B Deal Keeps Opioid Files Of J&J, Distributors Out Of View
• Fla. Hospital Faces New Trial In Amputee's Recalled Drug Suit
• DOJ Sues Pharmacist For Filling Illegal Opioid Prescriptions
• VW To Pay $3.5M To Settle Ohio Emissions Tampering Claims
• How Magistrate Judges Can Help Tame Large Product MDLs
• Texas Justices Revive Fatal Navy Helicopter Crash Suit
• What To Do As PFAS Food Packaging Phaseouts Approach
• Corporate Boards Need Not Fear 7th Circ. Boeing Decision
• House Climate Deception Probe Ensnares Oil Co. Directors
• Feds Urge High Court To Back Doctors' Opioid Convictions
• FCA OKs Proportionate Damages For Honeywell, DC Circ. Told
• Clinical Trial Staffer Gets 30 Months For Research Fraud
• Honda Secures $2.9M Deal To End Acura Touch-Screen Suit
• Split Panel Affirms $3.2M Fee Award Against Philip Morris
• Baby Pillow Co. 'Refusing' CPSC's Recall Ask After Deaths
• 9th Circ. Rejects Pre-Scandal VW Car Owners' Damages Fight
• Context Is Key In Agriculture Equipment Manufacturer Defense
• 6 Maura Healey Cases To Know As Gov. Campaign Launches
• EPA Must Close PFAS Reporting Loopholes, Suit Says
• 3rd Circ. Skeptical Of Reviving ERISA Row Over Asbestos In J&J Powder
• Smoking Was Bladder Cancer Patient's Choice, RJR Tells Jury
• Sanofi Tells 10th Circ. It Paid $36M To Access EpiPen Market
• NJ High Court Skeptical Of Union Carbide Asbestos Verdict
• Insurers Must Hand Over Info To $200M Verdict Winners
• DOT Defends Truckers' Hours Rule In DC Circ. Row
• Emails In Ex-CEO's Oxy Trial Cut Both Ways On Compliance
• Drugmakers Want Discovery From Valisure In Zantac MDL
• Nestle Says Coffee-Mate Buyers Misjudged Serving Size
• FTC Cracks Down On COVID Ad Claims Amid Omicron Surge
• The Rising Demand For Commercial Litigators In 2022
• Canadian Model Wants $50M Allergan Unit Suit To Proceed
• NJ Bankruptcy Judge Undoes Split Of J&J Tort Committee
• No New Trial For Smith & Nephew Hip Implant Patient
• Purdue Urges 2nd Circ. To Quickly Undo Ch. 11 Plan Rejection
• Gilead Says Counterfeit Ring Swiped Its HIV Drug Branding
• Delivery Driver's Mom Sues Amazon Over Ill. Facility Collapse
• Endo's Newest Opioid Deal Earmarks $65M For Fla.
• Insurer Sues Dehumidifier Manufacturer For Fire Damages
• Tribe Says Its Opioid Suit Was Not Harmed By Dropped Claim
• Unvaccinated Ex-Aegerion Rep Can't Delay 4-Year Fraud Term
• 4th Circ. Frees Six Flags In Attendee's Slide Injury Suit
• Ex-CEO's Atty Blasts Feds' 'Sales Over Safety' Oxy Charges
• When Fair Notice Precludes Punitive Damages
• 5th Circ. Clears Insurer In $20M Magnet Injury Settlement
• Judge Had Exxon Stock While Overseeing Case, Insurer Says
• Teligent's 3 Ch. 11 Asset Sales Bring $87M Into Estate
• Law360 Names Practice Groups Of The Year
• The Firms That Dominated In 2021
• Pharma Exec's Drug Trafficking Trial Tests Bold Legal Theory
• J&J, New Mexico Ink $44M Opioid Settlement
• Judge Gives J&J Talc Unit's Ch. 11 Dismissal Bid Prominence
• Farming Co. Says John Deere Is Monopolizing Repair Market
• Fiat Chrysler Must Face Trimmed Infotainment Defect Suit
• Aviation Watch: Resolving The FAA-FCC Fight Over 5G
• Drivers Denied Class Cert. In VW Preproduction Cars Suit
• Apple Reaches $14.8M Deal To End ICloud Storage Class Suit
• 'Rust' Armorer Blames Prop Supplier For Fatal Shooting
• 5th Circ. Backs Navistar In Suit Over Student's Death
• How In-House Counsel Can Make The Case For Settling Early
• Sens. Move Forward Nominees For FDA Chief, Labor Dept.
• SWAT Cop Says Not To Undo $7.5M Breaching Round Verdict
• Owens-Illinois Spinoff Proposes $610M Asbestos Claims Trust
• Pandemic Put Deep Freeze On State Trials, New Data Show
• Netflix Beats '13 Reasons Why' Suit Over Viewer Vulnerability
• Calif. Courts Can't Bar New Prop 65 Suits, 9th Circ. Told
• Fed. Circ. Tosses 1 Verdict, Affirms Another, Costing Texas Co.
• 9th Circ. Tosses Plane Crash Suit Against Aerospace Cos.
• Clinical Trial Co. Owner Admits Lying To FDA
• Amazon Buyer Tells 2nd Circ. Diet Pill Suit Must Be Tried
• To Retain Talent, GCs Should Prioritize Mission Statements
• Walgreens Sued Over 'Maximum Strength' Pain Relief Claims
• Supplement Co. Inks $1.7M Deal Ending Toxic Drink Claims
• Ex-Theranos CEO Elizabeth Holmes To Be Sentenced Sept. 26
• 1st Circ. Asks Mass. Court To Weigh In On Heart Valve Suit
• Plum Organics Can't Ditch Toxic Baby Food Claims
• Riddell Beats Helmet Bellwethers But Can't Dodge Defect Row
• Oil Cos. Must Pay $50M WWII Site Cleanup Bill, 9th Circ. Told
• 5th Circ. Cuts $4.3M Atty Fee In Defective-Toilet Settlement
• Pop-Tarts Don't Promise Fresh Fruit, Kellogg's Tells Court
• Cherokees Drop 'Public Nuisance' Theory In Opioid Bellwether
• 5th Circ. Finds Insurer Must Defend Roofing Co. In $5M Suit
• Confection Maker Dodges Claims It Fudged Package Amounts
• Judge Won't Lift Ch. 11 Injunction For J&J Talc Claims
• Del. High Court Gets It Right With Opioid Nuisance Ruling
• McKinsey Deal Not Enough For Opioid Costs, Mass. Suit Says
• Engineering Co. Still Faces Flint Water Study Claims At Trial
• Fla. Justices Nix Disbarment Appeal By Atty In NFL Player Plot
• Green Groups Urge 9th Circ. To Vacate EPA's Glyphosate OK
• High Court Declines Card Users' Swipe Fee Suit Against Banks
• Del. High Court Relieves Chubb Of Defending Opioid Suits
• Cos. Can't Beat Worker's Suit Over Faulty Fracking Parts
• Vineyards' Suit Against Monsanto, BASF Sent To State Court
• Boeing, Southwest Ask 5th Circ. To Void 737 Max RICO Class
• Supreme Court Won't Review Chinese Drywall Atty Fee Award
• High Court Won't Hear Off-Label Ad Suit Against Taro
• Split 7th Circ. Says Boeing Can't Curb 737 Max Derivative Suit
• Carlton Fields Adds 5 Attys To Growing LA Office
• Decision Delayed On Whether Talc Spinoff Stay Shelters J&J
• Aerospace Engineering Expert Can Testify In GM Engine Suit
• Ex-Theranos COO May Face Trial Delay Due To COVID Surge
• Yakama Nation Says Wash. City Can't Dodge CERCLA Suit
• Juul Execs Again Get Bellwether Claims Trimmed In Vape MDL
• How Attys For Long Island Counties Notched Opioid Trial Win
• Cos. To Pay $900K For Allegedly Giving DOD Chinese Goods
• Toyota, Family Settle $194M Lexus Seat Defect Claims
• Walgreens' Settlement History Will Stay Out Of SF Opioid Row
• Curaleaf Settles Suit Over Psychoactive CBD Drops
• AC Parts Maker Gets Early Win In Design Defect Suit
• 5th Circ. Sends $500K Remington Ruling To La. High Court
• Georgia Joins $26B US Opioid Settlement With J&J, Others
• Purdue Ch. 11 Appeal Can Go To 2nd Circ., NY Judge Rules
• Insurers Avoid Defending NY Manufacturer Against PFAS Suits
• Patent Row In Takata Ch. 11 Leads To Attorney Fee Award
• States Seek To Revive Trump Lead-Drinking Water Deadlines
• 4th Circ. Tosses Accident Suit Over Yamaha Motorcycle
• Mallinckrodt Says Ch. 11 Plan Fair For Acthar Claimants
• Wesson Oil False-Ad Class Wants Atty Fees Cut To Keep Deal
• Walmart, Belkin Want Router Speed Suit Booted To Arbitration
• Wells Fargo's $40M Deal With Foreclosed Homeowners OK'd
• Top 5 Drug And Medical Device Legal Issues Of 2021
• States Oppose Purdue's 2nd Circ. Appeal Try In Ch. 11 Case
• State Farm Suit Puts Amazon In Hot Water Over Faulty Bidet
• Civil Rights Complaint Filed Against Rhode Island Water Utility
• Mylan Can't Exclude Ex-CEO From EpiPen Antitrust Trial
• No Damages Do-Over For Syngenta Ads, Firms Say
• Key 2021 Cases On Standing In Product Defect Class Actions
• No DQ For NY Fed. Prosecutor In Opioid Case Against Ex-CEO
• Recent Bias Suits Against Law Firms And Lessons For 2022
• Damages Award Nixed In Child's MMR Vaccine Injury Dispute
• Ex-DEA Official Says Cardinal 'Barely' Monitored For Opioids
• Apple Crushes 'Loot Box' Gambling Suit For Good
• Ex-Boeing Technical Pilot's 737 Max Fraud Trial Set For March
• DuPont Escapes NY Water Contamination Claims For Now
• Stockholders Sue AmerisourceBergen In Del. Over Opioids
• Drivers' $33M Honda Infotainment Deal Gets Final OK
• SC Johnson Sued Over Ziploc's Food Preservation Claims
• Hospital Can't Undo $24M Verdict In Baby Brain Damage Suit
• Tolstoy Charity's Insurer Sues Over Property Water Damage
• PG&E Caused Catastrophic Dixie Fire, Calif. Officials Say
• 4 Takeaways From Elizabeth Holmes' Fraud Verdict
• Nevada Says It's Joining $26B Deal With Opioid Distributors
• Ill. Panel Won't Toss Or Transfer Conagra Cooking Spray Suits
• Fiat Chrysler Can't Decertify Classes In Gearshift MDL
• Acthar Claimants Call Mallinckrodt's Ch. 11 Plan Unfair
• Opioid Claims Involving McKinsey Should Be Axed, States Say
• Attys Seek $8.1M In Fees In Wells Fargo Foreclosure Deal
• Hair Product Biz Secures $5.2M Deal To End Hair Loss Claims
• Minn. Big Oil Climate Suit Follows Big Tobacco Blueprint
• Boston Scientific Says Dead-End SEC Probe Sinks Stock Suit
• Purdue's 2nd Circ. Appeal Request To Get Quick Decision
• Okla. Pot Farm Hit With RICO Suit From Angry Neighbors
• Jury Convicts Ex-Theranos CEO Elizabeth Holmes Of Fraud
• Holmes Jury Tells Judge It's Deadlocked On 3 Of 11 Counts
• Bankruptcy Cases To Watch In 2022
• 2021 ESG Litigation Offers Pointers For The Year Ahead
• Associate Hiring Outlook At Law Firms Is Bright For 2022
• Pennsylvania Litigation To Watch In 2022
• The Top New Jersey Cases To Watch In 2022
• Florida Cases To Watch In 2022
• A Blockbuster Year Ahead For Health, Life Sciences Litigation
• Food And Beverage Policy Trends To Track This Year
• Product Liability Regulation, Legislation To Watch: 2021
• 2022 Trials To Watch: Opioids, Oracle And Theranos Redux
• Transportation Cases To Watch In 2022
• Transportation Legislation And Regulation To Watch In 2022
• Product Liability Cases To Watch In 2022
• Biggest Environmental Policy Actions To Watch In 2022
• Biggest Environmental Cases To Watch In 2022